Plantar Fascitiis: Comparison of ESWT and Collagen Hydrolyzed Peptides (PFESWTCP)

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

Status and phase: Enrolling; Early Phase 1

Conditions: Plantar Fascitis

Treatments: Drug: Collagen hydrolyzed peptides

Study type: Interventional

Funder types: Other

Identifiers

NCT06138236

PFESWTCP

Details and patient eligibility

About

Patients suffering from Plantar Fasciitis were randomized into three groups:

the first group underwent infiltration of Collagen Hydrolyzed Peptides, the second one underwent the ESWT treatment, the third one underwent a combination of the two treatments.

Full description

Patients suffering from Plantar Fasciitis were randomized into three groups:

the first group underwent infiltration of Collagen Hydrolyzed Peptides, the second one underwent the ESWT treatment, the third one underwent a combination of the two treatments.

Aim of the study was to consider any difference in the outcome of the three groups of patients. The NRS and the AFAS score were considered for the outcome measurement.

Enrollment: 84 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Plantar fascitiis Aged between 18 and 80 years old

Exclusion criteria

• Previous surgery of the foot
• Contraindications to ESWT

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

84 participants in 3 patient groups

Infiltration

Experimental group

Description:

1. Infiltration of collagen hydrolyzed peptides

Treatment:

Drug: Collagen hydrolyzed peptides

ESWT(Extracorporeal Shockwave Therapy)

Experimental group

Description:

ESWT (Extracorporeal Shockwave Therapy)

Treatment:

Drug: Collagen hydrolyzed peptides

Combination

Experimental group

Description:

Combination of both treatments

Treatment:

Drug: Collagen hydrolyzed peptides